242PD Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792).
Telli, M Lord, S Dean, Emma J Abramson, V Arkenau, H-T Becerra, C Tolaney, S Tang, R Penney, M Pollard, J
Telli, M
Lord, S
Dean, Emma J
Abramson, V
Arkenau, H-T
Becerra, C
Tolaney, S
Tang, R
Penney, M
Pollard, J
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
242PD Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792). 2017, 28(suppl_5): Ann Oncol